Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.9200
+0.0510 (5.87%)
Jun 1, 2026, 1:08 PM EDT - Market open
Tenaya Therapeutics Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Tenaya Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $4.00. The average 1-year stock price forecast is 334.78% higher than the current stock price, while the lowest is $2.00 (+117.39%) and the highest is $8.00 (+769.57%).
Price Target: $4.00 (+334.78%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Tenaya Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 6 | 5 | 6 | 6 | 6 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 8 | 7 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $5 | Buy | Maintains | $5 | +443.48% | May 18, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $3 | Buy | Maintains | $3 | +226.09% | May 18, 2026 |
| Chardan Capital | Chardan Capital | Buy Reiterates $8 | Buy | Reiterates | $8 | +769.57% | May 15, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 15, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $3 → $4 | Buy | Reiterates | $3 → $4 | +334.78% | May 15, 2026 |
Financial Forecast
Revenue This Year
10.42M
Revenue Next Year
n/a
from 10.42M
EPS This Year
-0.39
from -0.59
EPS Next Year
-0.38
from -0.39
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 10.7M | n/a | ||||||
| Avg | 10.4M | n/a | ||||||
| Low | 10.0M | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.28 | -0.30 | ||||||
| Avg | -0.39 | -0.38 | ||||||
| Low | -0.58 | -0.46 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.